Bank Of America Corp Neuro Pace Inc Transaction History

Bank Of America Corp

$1.17 Trillion
Q4 2024

A detailed history of Bank Of America Corp transactions in Neuro Pace Inc stock. As of the latest transaction made, Bank Of America Corp holds 24,448 shares of NPCE stock, worth $271,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,448

Previous 13,360 82.99%

Holding current value

$271,128

Previous $93,000 193.55%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.9 - $11.93 $65,419 - $132,279	11,088 Added 82.99%	24,448 $273,000
Q3 2024 Nov 14, 2024	SELL	$6.65 - $8.46 $26,320 - $33,484	-3,958 Reduced 22.85%	13,360 $93,000
Q2 2024 Aug 14, 2024	BUY	$6.38 - $15.33 $23,044 - $55,371	3,612 Added 26.35%	17,318 $130,000
Q1 2024 May 15, 2024	SELL	$9.78 - $17.5 $177,986 - $318,482	-18,199 Reduced 57.04%	13,706 $180,000
Q4 2023 Feb 14, 2024	BUY	$5.9 - $10.31 $155,789 - $272,235	26,405 Added 480.09%	31,905 $328,000
Q2 2023 Aug 14, 2023	SELL	$3.98 - $5.12 $29,913 - $38,481	-7,516 Reduced 57.74%	5,500 $24,000
Q4 2022 Feb 10, 2023	BUY	$1.29 - $3.67 $14,460 - $41,140	11,210 Added 620.71%	13,016 $19,000
Q3 2022 Nov 14, 2022	SELL	$3.1 - $5.98 $4,247 - $8,192	-1,370 Reduced 43.14%	1,806 $7,000
Q2 2022 Aug 12, 2022	SELL	$4.95 - $8.7 $6,944 - $12,206	-1,403 Reduced 30.64%	3,176 $15,000
Q1 2022 May 16, 2022	SELL	$7.06 - $11.57 $16,230 - $26,599	-2,299 Reduced 33.43%	4,579 $38,000
Q4 2021 Feb 08, 2022	BUY	$8.63 - $17.36 $34,226 - $68,849	3,966 Added 136.2%	6,878 $69,000
Q3 2021 Nov 15, 2021	BUY	$15.85 - $25.07 $13,868 - $21,936	875 Added 42.96%	2,912 $46,000
Q2 2021 Sep 13, 2021	BUY	$19.03 - $26.5 $38,764 - $53,980	2,037 New	2,037 $48,000

Others Institutions Holding NPCE

# of Institutions

Shares Held

21.4M

Call Options Held

23.5K

Put Options Held

100

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $276M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Neuro Pace Inc Transaction History